Kang Ting
Physician · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · ·
History
Research
A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2
Review · Tissue engineering. Part B · 2016 · 893 citations
Tissue Engineering Part A · 2011 · 481 citations
Current development of biodegradable polymeric materials for biomedical applications
Review · Drug Designing Open Access · 2018 · 403 citations
126 papers · 15 as a resident
49 papers · 39 as a resident
39 papers · 37 as a resident
- BW
34 papers · 1 as a fellow
- JZ
25 papers · 23 as a resident
- CD
11 papers · 10 as a resident
- SB
11 papers · 9 as a resident
10 papers
Grants
- 2016–2024
Novel Peptide-Impregnated Hydrogel as a Wound Healing Device
National Institute of Dental and Craniofacial Research · R44
Contact PI · $902.5K · Scarless Laboratories, Inc.
- 2017–2022
Anti-Scar Peptide for Cleft Lip Repair
National Institute of Dental and Craniofacial Research · SB1
Contact PI · $882.8K · Scarless Laboratories, Inc.
- 2014–2020
NELL-1 Systemic Therapy for Osteoporosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $2M · University of California Los Angeles
- 2004–2011
Nell-1, A Cbfa 1 Downstream Target, In Bone Formation
National Institute of Dental and Craniofacial Research · R01
Contact PI · $2.1M · University of California Los Angeles